Fintech PR
J.S. Held Marks a Year of Global Leadership, Innovation, & Expert Collaboration in 2023
JERICHO, N.Y., March 20, 2024 /PRNewswire/ — Global consulting firm J.S. Held, proudly celebrating 50 transformative years, capped off 2023 with record revenue and strategic achievements that underscore the firm’s enduring commitment to innovation, growth, and team excellence.
In a testament to extraordinary team vision, hard work, and dedication, J.S. Held navigated both the smooth and turbulent waters of 2023 with remarkable client success. “I am incredibly proud of our team’s hard work and collaboration, which have not only propelled us to new heights of success but continually made J.S. Held a truly great place to work,” stated Jonathon Held, President & Chief Executive Officer of J.S. Held.
Navigating Success Through Challenge and Growth
J.S. Held’s collaborative team spirit and collective effort led to unprecedented achievements, enhancing its suite of services, and expanding its global client base. J.S. Held experts now serve as trusted advisors to organizations across six continents. More than 1,500 experts across the firm work with:
- 81% of the Global 200 Law Firms
- 70% of the Forbes Top 20 Insurance Companies (85% of the NAIC Top 50 Property & Casualty Insurers)
- 65% of the FORTUNE 100 Companies
2023 Featured Engagements
Working for clients in 80+ countries, J.S. Held experts supported more than 60,000 client engagements in 2023, including:
- J.S. Held’s experts set the stage and pioneered the use of virtual reality headsets in Southern California Courts.
- Representing a publicly traded renewable energy company at arbitration through their counsel, our expert testified in deposition and at arbitration. Leveraging the expertise of our Renewable Energy, Forensic Accounting, and Equipment Consulting, our Economic Damages & Valuation team assisted counsel in cutting the initial claim by tens of millions and denying the other party the right to claim legal fees.
- Served as an expert witness for the Australian tax authority in the first case to consider Diverted Profits Tax in that country.
- Advising multi-national extractive companies on their exposure to political and ‘above ground’ risk in a range of markets in Africa, including Nigeria, Ghana, Burkina Faso, Uganda and the Democratic Republic of the Congo. Our work has involved multi-phase assessments of political/economic risk, regulation and government interference, security and on-the-ground operational challenges – such as artisanal mining.
- Providing engineering, cost consulting, and remediation expertise to the insurance market, our Forensic Architecture & Engineering experts, leveraging experts in Building Consulting and Equipment Consulting, were engaged in a USD 400M+ fire loss.
- Serviced the receivership and co-authored the financial condition report filed in court outlining a purported multi-level “investment club,” through our Digital Investigations & Discovery, Global Investigations, and Corporate Finance teams.
- Provided owner’s representation services through our Construction Advisory team to oversee a USD 100M redevelopment project, managing 14 concurrent projects to remediate a former manufacturing site, overseeing the adaptive reuse of the 125-year-old facility, the project recognized as NAIOP Developer of the Year, NAIOP Mixed-Use Development of the Year, and ICRI Award of Excellence in Masonry Repair.
- Our Healthcare Consulting experts are leading an operational improvement process and guiding the creation of a new model of care for a target patient population for one of the largest addiction recovery and behavioral health companies. Our experts’ work in phase 1 of the model of care efforts resulted in the organization securing a USD 10M philanthropic gift to fund the build of the new model of care.
Leadership and Innovation at the Forefront
In 2023, J.S. Held welcomed new leadership to the firm, including Chief Financial Officer Stephen Lieberman, Chief Information Officer Dave Melchers, and Global Investigations Practice Lead Greg Esslinger, whose diverse expertise has contributed to our success and will undoubtedly continue to do so moving forward. Moreover, the launch of J.S. Held Academy and the graduation of the first risers cohort from J.S. Held’s LEDR™ program highlight our investment in continuous learning and building a succession pipeline through leadership capability development.
Growth Through Strategic Partnerships
Our Corporate Development team continues to support the growth and development of J.S. Held, amplifying our human capital resources in important geographies throughout North America and Europe and bolstering our laboratory testing capabilities. In 2023, we further strengthened our expertise in Accident Reconstruction, Corporate Finance, Construction Advisory, Economic Damages & Valuation, Equipment Consulting, Environmental Health & Safety, Global Investigations, and Intellectual Property via strategic transactions.
Embracing the Future with Confidence
As J.S. Held looks toward the future, we remain committed to delivering industry-leading support and innovative solutions. “As we celebrate our 50th anniversary in 2024, we do so with a firm foundation and a clear vision for continued success, thanks to the dedication of our exceptional team,” remarked CEO Jonathon Held.
J.S. Held’s journey through 2023 exemplifies its resilience, innovation, and leadership in the global consulting arena. With a half-century legacy of excellence, the firm is well-positioned for steady growth and success.
Learn more about the dedicated and entrepreneurial experts who help transform J.S. Held, explore our story, and celebrate this momentous milestone, during the 50 & Forward celebration, at jsheld.com.
About J.S. Held
J.S. Held is a global consulting firm that combines technical, scientific, financial, and strategic expertise to advise clients seeking to realize value and mitigate risk. Our professionals serve as trusted advisors to organizations facing high stakes matters demanding urgent attention, staunch integrity, proven experience, clear-cut analysis, and an understanding of both tangible and intangible assets.
The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.
J.S. Held, its affiliates and subsidiaries are not certified public accounting firm(s) and do not provide audit, attest, or any other public accounting services. J.S. Held, its affiliates and subsidiaries are not law firms and do not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB, a part of J.S. Held, member FINRA/ SIPC or Ocean Tomo Investment Group, LLC, a part of J.S. Held, member FINRA/ SIPC. All rights reserved.
Media Contact
Kristi L. Stathis, J.S. Held, +1 786 833 4864, [email protected], JSHeld.com
Logo – https://mma.prnewswire.com/media/1824221/JS_Held_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/js-held-marks-a-year-of-global-leadership-innovation–expert-collaboration-in-2023-302093682.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News7 days ago
Money20/20 Asia 2024: Days Two Roundup
-
Latest News4 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News7 days ago
Stripe Unveils Unbundled Payments Strategy in Fintech Pivot
-
Latest News4 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News6 days ago
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.
-
Latest News6 days ago
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
-
Latest News3 days ago
Talino, Chemonics invest in startup Higala, the Philippines’ pioneering inclusive instant payment system